Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Admission to hospital
[104] RCT 3-armed trial	17,118 people with vascular disease	Hospital admission for heart failure 394/8542 (5%) with telmisartan 354/8576 (4%) with ramipril	RR 1.12 95% CI 0.97 to 1.29 Non-inferiority not satisfied (see further information on studies)		Not significant